Literature DB >> 20149309

Does acute synovitis (pseudogout) occur in patients with chronic pyrophosphate arthropathy (pseudo-osteoarthritis)?

N Schlesinger1, A L Hassett, L Neustadter, H R Schumacher.   

Abstract

OBJECTIVES: Pyrophosphate arthropathy has been linked to diverse clinical subtypes. The two most common are: acute synovitis (pseudogout) and chronic pyrophosphate arthropathy ("pseudo-osteoarthritis"). We have conducted a study to examine whether these are overlapping syndromes.
METHODS: We reviewed all synovial fluid (SF) analyses performed in our laboratory from January 1988 to May 1997 to determine if patterns of SF leukocyte counts and Alizarin red stains in patients with repeated samples suggest that some patients were prone to acute attacks and some to chronic pyrophosphate arthropathy and whether acute attacks superimposed on chronic symptoms were common. Joint x-rays were screened for osteoarthritis (OA) and chondrocalcinosis.
RESULTS: We identified 67 patients who had Calcium pyrophosphate dehydrate (CPPD) in their SF and had more than one SF examined (185 SF). We divided the patients into 2 groups. Group A (n=25) had at least one SF leukocyte count > than 2000 per mm(3) and group B (n=42) had SF leukocyte counts always < than 2000 per mm(3). Chondrocalcinosis detected on x-ray was more common in group A versus group B, 48% versus 19% (p<0.05, Fisher's exact test). OA was mild (grades 0-1) in 39% of group A versus 12.5% of group B patients, but the difference between groups was not significant. CPPD crystals were not detected in 13.5% SFs previously having CPPD crystals. Alizarin red staining for suspected hydroxyapatite was more often 2+ to 3+ in group B (31.6%) compared to group A (15.5%; p<0.05, Fisher's exact test).
CONCLUSION: Acute synovitis and chronic pyrophosphate arthropathy are often two distinctive syndromes with some patients never having inflammatory attacks. Acute synovitis is more common in patients with chondrocalcinosis while chronic pyrophosphate arthropathy is associated with increased alizarin red staining and a trend suggestive of increased severity of OA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20149309

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

1.  Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro.

Authors:  Francesca Oliviero; Paolo Sfriso; Anna Scanu; Ugo Fiocco; Paolo Spinella; Leonardo Punzi
Journal:  Front Pharmacol       Date:  2013-04-17       Impact factor: 5.810

2.  Do not hallow until you are out of the wood! Ultrasonographic detection of CPP crystal deposits in menisci: facts and pitfalls.

Authors:  Georgios Filippou; Antonella Adinolfi; Panagiotis Bozios; Sauro Lorenzini; Valentina Picerno; Valentina Di Sabatino; Ilaria Bertoldi; Dario Gambera; Mauro Galeazzi; Bruno Frediani
Journal:  ScientificWorldJournal       Date:  2013-07-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.